Who should pay for HTA?

Pharmaphorum

11 June 2018 - Part of the drive for strengthening EU cooperation on health technology assessment is to tackle duplication of work – ‘double paying’ would be another way to put this.

To do this the European Commission has commissioned research which not only sheds a light on governments’ spending on health technology assessment (HTA), but also whether fees are charged. However, unanswered questions remain, including: given how much it HTA costs, who should pay?

The European Commission asked for a great deal of research to support their policy making in relation to HTA across Europe. As part of that work, mapping was conducted which has set out – where available – the budget allocated for HTA in member states.

Read Pharmaphorum article

Michael Wonder

Posted by:

Michael Wonder